MedLife launches the EarlyCDT® test, which allows early detection of lung cancer by identifying specific autoantibodies, available in all its units.
Delia Niculescu
Current Affairs
foto:shutterstock
Always see our news on Google
MedLife Group, the leading private healthcare provider in Romania, has introduced the EarlyCDT® test, a blood-based immunologic test for the early detection of lung cancer. It identifies autoantibodies produced by the body up to 4 years before visible lesions appear. The test is non-invasive and is mainly targeted at people with risk factors, with a turnaround time of about 15 days. Studies show that the use of this test reduces late-stage diagnoses by 36%, increasing the chances of survival. MedLife reaffirms its commitment to innovation in laboratory medicine.
Sources
MedLife introduce în premieră în România testul EarlyCDT®, un test de sânge pentru depistarea timpurie a cancerului pulmonar
Inovație în medicina de laborator: MedLife introduce în premieră în România testul EarlyCDT®, un test de sânge pentru depistarea timpurie a cancerului pulmonar
MedLife introduce în premieră în România testul EarlyCDT®, un test de sânge pentru depistarea timpurie a cancerului pulmonar
Latest News
22:56
Germany will participate with aircraft in the first military exercise of the Coalition of the Willing for Ukraine, which will also partly take place in Romania
22:37
Alexandru Nazare, on the audit requested by Sorin Grindeanu at all ministries: “There is absolutely no problem, it is actually a joy”
22:23
Traian Băsescu claims that Sorin Grindeanu will control the government through Marian Neacșu, while Prime Minister Luca Niculescu could become the target of criticism
22:09
Tens of thousands of Czechs protested in Prague against the reform of public media funding
21:57
Painting by Nicolae Grigorescu, valued at only 3 lei and 50 bani, at the Art Museum in Ploiești
See more news
NEWS ON THE SAME TOPICS
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
